Recombinant Bacillus Calmette-Guérin (rBCG) is a genetically modified form of the BCG vaccine, originally used to prevent tuberculosis. Through genetic engineering, rBCG is enhanced to carry additional antigens, making it a versatile tool in developing vaccines for various infectious diseases beyond tuberculosis.
